Evaluation of tofacitinib on B cell subsets in patients with rheumatoid arthritis

【Author】

Wang J.;Ju B.;He L.;

【Abstract】

<正>Objective: Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis(RA). Altered B cell subsets have been reported in RA patients pathology. This study was undertaken to evaluate the effects of tofacitinib on B memory subsets in RA patients.

【Keywords】

Evaluation of tofacitinib on B cell subsets in patients with rheumatoid arthritis;

References

To explore the background and basis of the node document

Springer Journals Database

Total: 0 articles

Similar documents

Documents that have the similar content to the node document

Springer Journals Database

Total: 0 articles